Logo image
Chemotherapy-Associated Hepatotoxicities
Journal article   Peer reviewed

Chemotherapy-Associated Hepatotoxicities

Michael A. White, Yuman Fong and Gagandeep Singh
Surgical Clinics of North America, Vol.96(2)
2016

Abstract

Antineoplastic Agents Drug-Induced Liver Injury Humans fluorouracil irinotecan oxaliplatin antineoplastic agent ablation therapy Article artificial embolism bleeding cancer chemotherapy cancer combination chemotherapy cancer recurrence cancer specific survival cancer survival colorectal cancer colorectal liver metastasis computer assisted tomography echography fatty liver histopathology human liver injury liver metastasis liver resection liver toxicity liver venoocclusive disease nonalcoholic fatty liver nuclear magnetic resonance imaging overall survival patient safety priority journal toxic hepatitis treatment duration treatment outcome treatment planning Drug-Induced Liver Injury
Chemotherapy can cause liver injury, which should be considered when planning for safe surgical hepatic resections. This article reviews the pertinent clinical findings and applications for surgeons to take into account in evaluating patients for hepatic resection with liver injury secondary to chemotherapy. A selection of the pertinent literature discussing types of chemotherapy-associated hepatotoxicities, mechanisms of injury, methods for identification of liver injury, and impact on surgical outcomes is discussed. © 2016 Elsevier Inc.

Metrics

5 Record Views

Details

Logo image